Greater Manchester Cancer: Referral, Assessment & Management for Suspected Sarcomas

 
R
e
f
e
r
r
a
l
 
&
 
A
s
s
e
s
s
m
e
n
t
 
f
o
r
S
u
s
p
e
c
t
e
d
 
S
o
f
t
 
T
i
s
s
u
e
 
&
 
B
o
n
e
S
a
r
c
o
m
a
s
A
m
i
t
 
K
u
m
a
r
12
th
 October 2019
 
 
G
r
e
a
t
e
r
 
M
a
n
c
h
e
s
t
e
r
 
C
a
n
c
e
r
 
A
i
m
s
 
G
r
e
a
t
e
r
 
M
a
n
c
h
e
s
t
e
r
 
C
a
n
c
e
r
 
Increase awareness of MSK tumours
 
Appropriately manage a patient with a concerning lump
/ suspected bone tumour
 
O
b
j
e
c
t
i
v
e
s
 
G
r
e
a
t
e
r
 
M
a
n
c
h
e
s
t
e
r
 
C
a
n
c
e
r
 
Background
Symptoms & Signs
Clinical assessment
Initial Management
Referral Criteria
 
M
u
s
t
 
R
e
a
d
 
G
r
e
a
t
e
r
 
M
a
n
c
h
e
s
t
e
r
 
C
a
n
c
e
r
 
NICE Sarcoma Guidelines
Familiarity with 2WW local referral form
 
Sarcoma UK
Bone Cancer Research UK
 
I
n
t
r
o
d
u
c
t
i
o
n
 
G
r
e
a
t
e
r
 
M
a
n
c
h
e
s
t
e
r
 
C
a
n
c
e
r
 
A rare type of cancer arising from
mesenchymal/
connective tissue
Soft Tissue, Bone or GIST
1% of all primary cancer
Approx 5300 per year (15/day)
100 different sub-types.
5 year survival rate for sarcoma is 55%
 
S
a
r
c
o
m
a
 
G
r
e
a
t
e
r
 
M
a
n
c
h
e
s
t
e
r
 
C
a
n
c
e
r
 
40-60 years, young adults, children
 
No significant aetiology
 
Associations: HIV / Kaposis, Neurofibromatosis,
other cancers 
 2
nd
 hit hypothesis
 
50% extremities: LL > UL
 
Other: Retroperitoneal, Chest, Gynae, Breast
 
World Health Organization classification of
tumours
 
Tumours are classified by differentiation and biological behaviour.
Adipocytic tumours
Fibroblastic/myofibroblastic tumours
So-called fibrohistiocytic tumours
Smooth-muscle tumours
Skeletal muscle tumours
Vascular tumours
Chondro-osseous tumours
Gastrointestinal stromal tumours
Nerve sheath tumours
Tumours of uncertain differentiation
Undifferentiated/unclassified sarcomas.
 
Common Sarcomas
 
Soft Tissue
 
Leiomyosarcoma
Fibroblastic Sarcoma
Liposarcoma
Rhabdomyosarcoma
Malignant peripheral nerve
sheath tumour
Angiosarcoma
Synovial sarcoma
GIST
Kaposi’s
 
Bone
 
Ewings
Osteosarcoma
Chondrosarcoma
Chordoma
 
G
r
e
a
t
e
r
 
M
a
n
c
h
e
s
t
e
r
 
C
a
n
c
e
r
 
G
r
e
a
t
e
r
 
M
a
n
c
h
e
s
t
e
r
 
C
a
n
c
e
r
 
 
 
 
 
 
G
r
e
a
t
e
r
 
M
a
n
c
h
e
s
t
e
r
 
C
a
n
c
e
r
 
 
 
 
 
 
Approach to Patient with a lump
 
History:
How long
Painful
Increasing in size
Bigger than 5cm?
Previous surgery/Rxt
 
Discharge or skin changes
FHx 
 other cancers: melanoma, lymphoma, lung
 
Ask what has been done: other GP, hospital, private
 
G
r
e
a
t
e
r
 
M
a
n
c
h
e
s
t
e
r
 
C
a
n
c
e
r
 
Symptoms & Signs
 
Symptoms
 
Pain
Stiffness
Local effects
Non weight bearing
Vague symptoms
 
Signs
 
Noticeable lump
Joint swelling
Skin changes
Fungating tumour
 
 
G
r
e
a
t
e
r
 
M
a
n
c
h
e
s
t
e
r
 
C
a
n
c
e
r
Clinical Examination
 
G
r
e
a
t
e
r
 
M
a
n
c
h
e
s
t
e
r
 
C
a
n
c
e
r
 
Clinical Examination
 
Look
: skin changes, naevi, neurofibromas,
multiple lumps
Feel/Move:
Location 
 limb, trunk, areas of lymph nodes?
Soft or hard
Mobile or adherent to deeper structures
Size >5cm?
Pain
Joint function
Neurological symptoms
 
G
r
e
a
t
e
r
 
M
a
n
c
h
e
s
t
e
r
 
C
a
n
c
e
r
 
Investigations
 
Basic Work up:
 
Ultrasound: Will rule out most benign
 
MRI (Tumour protocol)
 
Limb Xray
 
CXR
 
Baseline Bloods
Bone Profile/Calcium
 
G
r
e
a
t
e
r
 
M
a
n
c
h
e
s
t
e
r
 
C
a
n
c
e
r
 
WHOOPS
 
Do NOT  not biopsy
Do NOT excise without imaging and discussion
If in-advertent incision 
 biopsy and close
 
2
W
W
 
R
e
f
e
r
r
a
l
 
C
r
i
t
e
r
i
a
 
G
r
e
a
t
e
r
 
M
a
n
c
h
e
s
t
e
r
 
C
a
n
c
e
r
 
 
Lump increasing in size, deep, bigger than 5cm
 
Painful, fungating, previous surgery, Rxt
 
Bone changes on Xray
 
 
2
W
W
 
R
e
f
e
r
r
a
l
 
F
o
r
m
 
G
r
e
a
t
e
r
 
M
a
n
c
h
e
s
t
e
r
 
C
a
n
c
e
r
 
G
r
e
a
t
e
r
 
M
a
n
c
h
e
s
t
e
r
 
C
a
n
c
e
r
 
Sarcoma Service
 
Clinical assessment
Imaging
Biopsy: Core biospy. 
No role for FNA
Histopathology
MDT review locally
Regional MDT
Management Plan
 
G
r
e
a
t
e
r
 
M
a
n
c
h
e
s
t
e
r
 
C
a
n
c
e
r
 
Treatment
 
Surgical Excision: Marginal, Wide, Amputation
Pre or Post op Radiotherapy
Chemotherapy
Palliative treatment
 
G
r
e
a
t
e
r
 
M
a
n
c
h
e
s
t
e
r
 
C
a
n
c
e
r
 
Pitfalls in patient pathway
 
Delayed referral 
 biggest cause of litigation
Patients referred to non-tumour specialists
Poor knowledge of tumours and clinical skills
WHOOPS
Where are the scans? Urgent? 2WW?
Beware the persistent haematoma
Not taking a history
 
Sarcoma
Clinic
GP
Referral
Specialist
Referral
Soft Tissue
Mass/Bone
lesion
Diagnostic
Clinic
USS + Bx
GMOSS
MDT
MRI / CT
Return to
referrer
Refer to
other
specialty
G
M
O
S
S
G
r
e
a
t
e
r
 
M
a
n
c
h
e
s
t
e
r
 
&
 
O
s
w
e
s
t
r
y
 
S
a
r
c
o
m
a
 
S
e
r
v
i
c
e
S
o
f
t
 
T
i
s
s
u
e
 
&
 
B
o
n
e
 
G
u
i
d
e
l
i
n
e
s
Arrange
Surgery
Sarcoma
Diagnostic
Triage/MDM
 
C
u
r
r
e
n
t
 
P
a
t
i
e
n
t
 
P
a
t
h
w
a
y
 
G
r
e
a
t
e
r
 
M
a
n
c
h
e
s
t
e
r
 
C
a
n
c
e
r
 
 
Clinic and/or MDT < 2 weeks
Biopsy < 2 weeks
Results and MDT 2-3 weeks
Back to C
l
inic
Total = Min 6 weeks
N
H
S
 
E
n
g
l
a
n
d
 
G
r
e
a
t
e
r
 
M
a
n
c
h
e
s
t
e
r
 
C
a
n
c
e
r
 
Doctor, I have got a lump, what do I
do with it?
 
G
r
e
a
t
e
r
 
M
a
n
c
h
e
s
t
e
r
 
C
a
n
c
e
r
 
History: how long, is it getting bigger and painful
Examine to see is it soft, hard, mobile and deep;
joint swelling 
 Xrays?
 
Refer to local sarcoma service if meets criteria
 
Discuss/refer if concerned
 
Its not a pathway for: Unknown malignancy, get seen quicker, small benign proven
lumps
 
T
h
a
n
k
 
y
o
u
 
G
r
e
a
t
e
r
 
M
a
n
c
h
e
s
t
e
r
 
C
a
n
c
e
r
Slide Note
Embed
Share

This content provides comprehensive information on Greater Manchester Cancer referral and assessment for suspected soft tissue and bone sarcomas. It covers objectives, background, symptoms, signs, clinical assessment, initial management, and referral criteria. Essential guidelines and key points on sarcoma classification, common types, and WHO tumor classification are outlined. The document emphasizes the importance of early detection, familiarity with referral forms, and awareness of different subtypes of sarcomas, aiming to improve patient outcomes and increase survival rates.

  • Greater Manchester Cancer
  • Sarcomas
  • Soft Tissue
  • Bone
  • Referral Criteria

Uploaded on Aug 07, 2024 | 0 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

E N D

Presentation Transcript


  1. Greater Manchester Cancer Referral & Assessment for Suspected Soft Tissue & Bone Sarcomas Amit Kumar 12thOctober 2019

  2. Greater Manchester Cancer Aims Increase awareness of MSK tumours Appropriately manage a patient with a concerning lump / suspected bone tumour

  3. Greater Manchester Cancer Objectives Background Symptoms & Signs Clinical assessment Initial Management Referral Criteria

  4. Greater Manchester Cancer Must Read NICE Sarcoma Guidelines Familiarity with 2WW local referral form Sarcoma UK Bone Cancer Research UK

  5. Greater Manchester Cancer Introduction A rare type of cancer arising from mesenchymal/connective tissue Soft Tissue, Bone or GIST 1% of all primary cancer Approx 5300 per year (15/day) 100 different sub-types. 5 year survival rate for sarcoma is 55%

  6. Greater Manchester Cancer Sarcoma 40-60 years, young adults, children No significant aetiology Associations: HIV / Kaposis, Neurofibromatosis, other cancers 2nd hit hypothesis 50% extremities: LL > UL Other: Retroperitoneal, Chest, Gynae, Breast

  7. World Health Organization classification of tumours Tumours are classified by differentiation and biological behaviour. Adipocytic tumours Fibroblastic/myofibroblastic tumours So-called fibrohistiocytic tumours Smooth-muscle tumours Skeletal muscle tumours Vascular tumours Chondro-osseous tumours Gastrointestinal stromal tumours Nerve sheath tumours Tumours of uncertain differentiation Undifferentiated/unclassified sarcomas.

  8. Greater Manchester Cancer Common Sarcomas Soft Tissue Leiomyosarcoma Fibroblastic Sarcoma Liposarcoma Rhabdomyosarcoma Malignant peripheral nerve sheath tumour Angiosarcoma Synovial sarcoma GIST Kaposi s Bone Ewings Osteosarcoma Chondrosarcoma Chordoma

  9. Greater Manchester Cancer

  10. Greater Manchester Cancer

  11. Greater Manchester Cancer Approach to Patient with a lump History: How long Painful Increasing in size Bigger than 5cm? Previous surgery/Rxt Discharge or skin changes FHx other cancers: melanoma, lymphoma, lung Ask what has been done: other GP, hospital, private

  12. Greater Manchester Cancer Symptoms & Signs Symptoms Pain Stiffness Local effects Non weight bearing Vague symptoms Signs Noticeable lump Joint swelling Skin changes Fungating tumour

  13. Clinical Examination

  14. Greater Manchester Cancer Clinical Examination Look: skin changes, naevi, neurofibromas, multiple lumps Feel/Move: Location limb, trunk, areas of lymph nodes? Soft or hard Mobile or adherent to deeper structures Size >5cm? Pain Joint function Neurological symptoms

  15. Greater Manchester Cancer Investigations Basic Work up: Ultrasound: Will rule out most benign MRI (Tumour protocol) Limb Xray CXR Baseline Bloods Bone Profile/Calcium

  16. Greater Manchester Cancer WHOOPS Do NOT not biopsy Do NOT excise without imaging and discussion If in-advertent incision biopsy and close

  17. Greater Manchester Cancer 2WW Referral Criteria Lump increasing in size, deep, bigger than 5cm Painful, fungating, previous surgery, Rxt Bone changes on Xray

  18. Greater Manchester Cancer 2WW Referral Form

  19. Greater Manchester Cancer Sarcoma Service Clinical assessment Imaging Biopsy: Core biospy. No role for FNA Histopathology MDT review locally Regional MDT Management Plan

  20. Greater Manchester Cancer Treatment Surgical Excision: Marginal, Wide, Amputation Pre or Post op Radiotherapy Chemotherapy Palliative treatment

  21. Greater Manchester Cancer Pitfalls in patient pathway Delayed referral biggest cause of litigation Patients referred to non-tumour specialists Poor knowledge of tumours and clinical skills WHOOPS Where are the scans? Urgent? 2WW? Beware the persistent haematoma Not taking a history

  22. GMOSS Greater Manchester & Oswestry Sarcoma Service Soft Tissue & Bone Guidelines GP Specialist Referral Referral Return to referrer Soft Tissue Mass/Bone lesion Diagnostic Clinic USS + Bx Sarcoma Diagnostic Triage/MDM Refer to other specialty Arrange Surgery Sarcoma Clinic MRI / CT GMOSS MDT

  23. Greater Manchester Cancer Current Patient Pathway Clinic and/or MDT < 2 weeks Biopsy < 2 weeks Results and MDT 2-3 weeks Back to Clinic Total = Min 6 weeks

  24. Greater Manchester Cancer NHS England

  25. Greater Manchester Cancer Doctor, I have got a lump, what do I do with it? History: how long, is it getting bigger and painful Examine to see is it soft, hard, mobile and deep; joint swelling Xrays? Refer to local sarcoma service if meets criteria Discuss/refer if concerned Its not a pathway for: Unknown malignancy, get seen quicker, small benign proven lumps

  26. Greater Manchester Cancer Thank you

Related


More Related Content

giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#